Tactile Medical Q2 2026 results: Revenue up 9% to $85.7M
Tactile Systems Technology reported strong Q2 2026 financials with revenue reaching $85.7 million and expanded margins. The company paused Airway Clearance sales to manage inventory during the AffloVest launch.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day